DK
Dilip Kumar Pandey
About Dilip Kumar Pandey
Data last updated:
Dilip Kumar Pandey is a Director at Smith And Sapphire Bio-Tech Limited (since 2016). The companies operate in Pharma. Earlier, Dilip Kumar Pandey was an Additional Director at Babuji Overseas Private Limited (from 2016) and Director at Sangaria Private Limited (from 2017).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 28 May 2016 | 1995 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Additional Director | 15 Dec 2016 | 2014 | ₹18.3 Lakh (FY 2017) | Strike Off | |
| Director | 24 Mar 2017 | 2012 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Dilip Kumar Pandey
| Name | DIN | Company | Designation |
|---|---|---|---|
| Mahmud Kazi | 07431500 | Smith And Sapphire Bio-Tech Limited | Director |
| Rohit Choudhary Kumar | 07431498 | Smith And Sapphire Bio-Tech Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Dilip Kumar Pandey
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Dilip Kumar Pandey
Dilip Kumar Pandey currently holds 1 directorship: Smith And Sapphire Bio-Tech Limited (Director, since 28 May 2016).
Dilip Kumar Pandey was first appointed on 28 May 2016 as Director at Smith And Sapphire Bio-Tech Limited. The most recent appointment on record is 24 Mar 2017 at Sangaria Private Limited.
Dilip Kumar Pandey held 2 earlier board appointments: Babuji Overseas Private Limited (Additional Director, from 15 Dec 2016); Sangaria Private Limited (Director, from 24 Mar 2017).
The current boards of Dilip Kumar Pandey's companies include Mahmud Kazi (Smith And Sapphire Bio-Tech Limited), Rohit Choudhary Kumar (Smith And Sapphire Bio-Tech Limited).